Tempus AI (TEM), the precision medicine and healthcare data analytics company, gained nearly 12% after beating third quarter expectations. Revenue increased 23% to $411.5m, while data and applications revenue grew 33%. Oncology volumes increased 32%. The company raised its 2026 revenue forecast.